PRNewsWire · BIIB · November 16, 2026New Five-Year Lecanemab Data from Clarity AD Study Long-Term Extension Presented at CTAD 2026Get the app for moreExplore stock news, insights and company research.Get the app →Source: PRNewsWire ↗